Comparing Revo-i and da Vinci in Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Preliminary Propensity Score Analysis of Outcomes

Alip, Sylvia Karina L.; Koukourikis, Periklis; Han, Woong Kyu; Rha, Koon Ho; Na, Joon Chae

doi:10.1089/end.2021.0421

Cited by 15 publications

(19 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several preclinical studies have shown its potential for use in gynecological surgeries, but no clinical studies have reported its use in this surgical specialty [18,19,21]. The performance of cholecystectomies [21], radical prostatectomies [22,23], and pancreatectomies [24] evidenced a short learning curve on its use [18], convenient console and video monitor, comfortable docking, outstanding camera resolution, few "foggy effects" of cautery, and effective articulated instruments [20,22,24].…”

Section: Resultsmentioning

confidence: 99%

New Robotic Platforms for Gynecology. Are We Achieving One of the Golden Goals?

Farinha¹,

Sarchi²,

Paciotti³

et al. 2022

Clin. Exp. Obstet. Gynecol.

View full text Add to dashboard Cite

Objective: To summarize the scientific published literature on new robotic platforms with potential use in gynecology and review their evolution from inception until the present day. The goal was to describe the current characteristics and possible prospects of these platforms. Mechanism: A non-systematic search of PubMed, Cochrane Library Central, EMBASE, MEDLINE, and Scopus databases was conducted to identify scientific literature on new robotic platforms and review their evolution from inception until January 2022. Only English-language publications were included in this analysis. The following keywords were used: "new robotic platforms", "robot", "Revo-I", "Versius®", "Senhance®", "Single-Site", "Single-Port", "Multi-Port", "EDGE SP1000", "Flex®", and "Hominis®". Abstract reviews were conducted to determine the relevance of the review aims. Full-text analysis of all relevant English-language original articles was subsequently performed by one author (R.F.) and summarized after discussion with an independent third party (L.S., M.P.). No formal quality assessment of the included studies was conducted. Findings in brief: The Da Vinci robotic system is the leading platform in the robotic surgery market. Other new platforms have published peer-reviewed articles in the field of gynecology. Senhance® and Da Vinci SP® have the most substantial proof of their capacity to perform multi-incision and single-incision robotic surgery, respectively. Hominis® has the potential to play a major role in ultra-minimally invasive and scarless approaches. Conclusions: The significant advantages of Intuitive's robots justify their worldwide dissemination. However, their drawbacks have motivated other companies to develop innovative solutions. Our research shows that the majority of these new platforms are still at the beginning of their technical and scientific validation but seem very promising.

show abstract

Section: Resultsmentioning

confidence: 99%

New Robotic Platforms for Gynecology. Are We Achieving One of the Golden Goals?

Farinha¹,

Sarchi²,

Paciotti³

et al. 2022

Clin. Exp. Obstet. Gynecol.

View full text Add to dashboard Cite

show abstract

“…Furthermore, not all SP-RARP are truly single-port as in some instances an additional port may be placed at the surgeon's discretion, an approach commonly known as the SP + 1. Both pure SP ( 28 , 65 , 80 ) and SP + 1 ( 67 , 79 , 81 – 83 ) approaches have been reported by prominent groups. In our experience, the SP + 1 was commonly used early in our experience with the SP robotic platform, but now it is reserved for complex cases where dynamic bedside assistance may be warranted.…”

Section: Discussionmentioning

confidence: 99%

“…The extraperitoneal approach may be indicated if planning for SDD as it minimizes peritoneal irritation, or for men with hostile abdomen and/or comorbidities at odds with maintaining a prolonged pneumoperitoneum ( 28 , 88 ). Transperitoneal Retzius-sparing SP-RARP has been reported with varying degrees of success, which was defined as avoiding conversion to an anterior approach ( 80 , 81 ). Other lesser known SP-RARP approaches include the transperineal and transvesical approaches, as previously described by Dr. Jihad Kaouk et al A transperineal SP-RARP was described in 26 patients with relative contraindications for a retropubic approach and noted to be technically challenging; however, it was associated with higher rates of positive surgical margins (23% vs. 65%) and comparable functional and oncological outcomes to those of the conventional MP-RARP at 12 months ( 89 ).…”

Section: Discussionmentioning

confidence: 99%

Robot-assisted radical prostatectomy: Advancements in surgical technique and perioperative care

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The first clinical study of Revo-I was for 17 patients undergoing Retzius-sparing RARP with successful completion of surgery and no conversions to open or laparoscopic surgery [ 20 ]. Subsequent comparisons have been made between the Revo-I and Da Vinci systems, although notably with the previous generation Si model, where there was no difference in short-term oncological times [ 39 ]. The authors also reported that the da Vinci Si system did have shorter operative duration but also a longer length of stay compared to the Revo-I [ 39 ].…”

Section: Revo-imentioning

confidence: 99%

“…Subsequent comparisons have been made between the Revo-I and Da Vinci systems, although notably with the previous generation Si model, where there was no difference in short-term oncological times [ 39 ]. The authors also reported that the da Vinci Si system did have shorter operative duration but also a longer length of stay compared to the Revo-I [ 39 ].…”

Section: Revo-imentioning

confidence: 99%

The Availability, Cost, Limitations, Learning Curve and Future of Robotic Systems in Urology and Prostate Cancer Surgery

Hughes

Rai

Madaan

et al. 2023

JCM

View full text Add to dashboard Cite

Robot-assisted surgical systems (RASS) have revolutionised the management of many urological conditions over the last two decades with robot-assisted radical prostatectomy (RARP) now being considered by many to be the preferred surgical approach. Intuitive Surgical has dominated the market during this time period with successive iterations of the da Vinci model. The expiration of patents has opened the RASS market and several new contenders have become available or are currently in development. This comprehensive narrative review aims to explore the merits of each robotic system as well as the evidence and barriers to their use. The newly developed RASS have increased the versality of robotic surgical systems to a wider range of settings through advancement in technology. The increased competition may result in an overall reduction in cost, broadening the accessibility of RASS. Learning curves and training remain a barrier to their use, but the situation appears to be improving through dedicated training programmes. Outcomes for RARP have been well investigated and tend to support improved early functional outcomes. Overall, the rapid developments in the field of robot-assisted surgery indicate the beginning of a promising new era to further enhance urological surgery.

show abstract

Comparing Revo-i and da Vinci in Retzius-Sparing Robot-Assisted Radical Prostatectomy: A Preliminary Propensity Score Analysis of Outcomes

Cited by 15 publications

References 17 publications

New Robotic Platforms for Gynecology. Are We Achieving One of the Golden Goals?

New Robotic Platforms for Gynecology. Are We Achieving One of the Golden Goals?

Robot-assisted radical prostatectomy: Advancements in surgical technique and perioperative care

The Availability, Cost, Limitations, Learning Curve and Future of Robotic Systems in Urology and Prostate Cancer Surgery

Contact Info

Product

Resources

About